196 related articles for article (PubMed ID: 21673386)
41. Bioeliminable polymeric nanoparticles for proteic drug delivery.
Chiellini F; Bartoli C; Dinucci D; Piras AM; Anderson R; Croucher T
Int J Pharm; 2007 Oct; 343(1-2):90-7. PubMed ID: 17580105
[TBL] [Abstract][Full Text] [Related]
42. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
Zhu A; Yuan L; Jin W; Dai S; Wang Q; Xue Z; Qin A
Acta Biomater; 2009 Jun; 5(5):1489-98. PubMed ID: 19286431
[TBL] [Abstract][Full Text] [Related]
43. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
44. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
de la Fuente M; Seijo B; Alonso MJ
Macromol Biosci; 2008 May; 8(5):441-50. PubMed ID: 18236434
[TBL] [Abstract][Full Text] [Related]
45. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.
Sahu A; Bora U; Kasoju N; Goswami P
Acta Biomater; 2008 Nov; 4(6):1752-61. PubMed ID: 18524701
[TBL] [Abstract][Full Text] [Related]
47. One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery.
Wang K; Yuan A; Yu J; Wu J; Hu Y
J Pharm Sci; 2016 Mar; 105(3):1269-76. PubMed ID: 26886339
[TBL] [Abstract][Full Text] [Related]
48. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
[TBL] [Abstract][Full Text] [Related]
49. Hollow and degradable polyelectrolyte nanocapsules for protein drug delivery.
Shu S; Sun C; Zhang X; Wu Z; Wang Z; Li C
Acta Biomater; 2010 Jan; 6(1):210-7. PubMed ID: 19531385
[TBL] [Abstract][Full Text] [Related]
50. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
[TBL] [Abstract][Full Text] [Related]
51. Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.
Brzoska M; Langer K; Coester C; Loitsch S; Wagner TO; Mallinckrodt Cv
Biochem Biophys Res Commun; 2004 May; 318(2):562-70. PubMed ID: 15120637
[TBL] [Abstract][Full Text] [Related]
52. Monodisperse chitosan nanoparticles for mucosal drug delivery.
Zhang H; Oh M; Allen C; Kumacheva E
Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
[TBL] [Abstract][Full Text] [Related]
53. A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation.
Jiang L; Xu Y; Liu Q; Tang Y; Ge L; Zheng C; Zhu J; Liu J
Int J Pharm; 2013 Feb; 443(1-2):80-6. PubMed ID: 23291446
[TBL] [Abstract][Full Text] [Related]
54. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
Tseng CL; Wang TW; Dong GC; Yueh-Hsiu Wu S; Young TH; Shieh MJ; Lou PJ; Lin FH
Biomaterials; 2007 Sep; 28(27):3996-4005. PubMed ID: 17570484
[TBL] [Abstract][Full Text] [Related]
55. Spectroscopic investigation on the binding of bioactive pyridazinone derivative to human serum albumin and molecular modeling.
Wang T; Xiang B; Wang Y; Chen C; Dong Y; Fang H; Wang M
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):113-9. PubMed ID: 18456467
[TBL] [Abstract][Full Text] [Related]
56. Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy.
Chen Q; Wang C; Zhan Z; He W; Cheng Z; Li Y; Liu Z
Biomaterials; 2014 Sep; 35(28):8206-14. PubMed ID: 24957292
[TBL] [Abstract][Full Text] [Related]
57. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy.
Jiang C; Cheng H; Yuan A; Tang X; Wu J; Hu Y
Acta Biomater; 2015 Mar; 14():61-9. PubMed ID: 25463484
[TBL] [Abstract][Full Text] [Related]
58. Computer simulation of the role of protein corona in cellular delivery of nanoparticles.
Ding HM; Ma YQ
Biomaterials; 2014 Oct; 35(30):8703-10. PubMed ID: 25005681
[TBL] [Abstract][Full Text] [Related]
59. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
60. Conformational modifications of serum albumins adsorbed on different kinds of biomimetic hydroxyapatite nanocrystals.
Iafisco M; Sabatino P; Lesci IG; Prat M; Rimondini L; Roveri N
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):274-84. PubMed ID: 20692819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
